Literature DB >> 17078040

High-level expression of DNA architectural factor HMGA2 and its association with nucleosomes in human embryonic stem cells.

Ou Li1, Dileep Vasudevan, Curt A Davey, Peter Dröge.   

Abstract

The state of chromatin in human embryonic stem (hES) cells is a key factor determining stem cell identity. The non-histone chromatin-associated factor HMGA2 has been studied mostly in the mouse where its function seems critical for embryonic cell growth and adipocytic cell differentiation. Here we show that HMGA2 is highly expressed in two undifferentiated human embryonic stem cell lines at a level of at least 10(5) copies per individual stem cell. Interestingly, expression is further upregulated by a factor of three at day 7 of embryoid body formation, before it quickly drops to or below the level found in undifferentiated cells. We also show that HMGA2 is stably associated with inter- and metaphase hES cell chromatin, and that up to 12 HMGA2 protomers stably associate in vitro with a single nucleosome core particle of known atomic structure. Our data lend support to the possibility that HMGA2 interacts with nucleosomes in a way that imposes a global effect on the state of ES cell chromatin, which may contribute to the establishment of both ES cell identity and the initiation of specific differentiation programs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17078040     DOI: 10.1002/dvg.20242

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  28 in total

1.  Gene-specific nucleotide excision repair is impaired in human cells expressing elevated levels of high mobility group A1 nonhistone proteins.

Authors:  Scott C Maloney; Jennifer E Adair; Michael J Smerdon; Raymond Reeves
Journal:  DNA Repair (Amst)       Date:  2007-05-30

2.  Insights into the regulation of a common variant of HMGA2 associated with human height during embryonic development.

Authors:  Yvonne Tay; Sabrina Peter; Isidore Rigoutsos; Paulette Barahona; Sohail Ahmed; Peter Dröge
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

3.  The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR-LIN28-LET7 signaling.

Authors:  I-I Kuan; Chi-Chiu Lee; Chien-Hsu Chen; Jean Lu; Yuan-Sung Kuo; Han-Chung Wu
Journal:  J Biol Chem       Date:  2019-03-29       Impact factor: 5.157

Review 4.  The dynamics of HMG protein-chromatin interactions in living cells.

Authors:  Gabi Gerlitz; Robert Hock; Tetsuya Ueda; Michael Bustin
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

5.  Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.

Authors:  Yong Yang; Peng Zhang; Yanfeng Zhao; Jie Yang; Gening Jiang; Jie Fan
Journal:  Cancer Biol Ther       Date:  2015-10-22       Impact factor: 4.742

6.  Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells.

Authors:  Jørn Henriksen; Marianne Stabell; Leonardo A Meza-Zepeda; Silje Au Lauvrak; Moustapha Kassem; Ola Myklebost
Journal:  BMC Cancer       Date:  2010-06-25       Impact factor: 4.430

7.  MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2.

Authors:  Shoukang Zhu; Shanming Deng; Qi Ma; Taifang Zhang; Chunling Jia; Degen Zhuo; Falin Yang; Jianqin Wei; Liyong Wang; Derek M Dykxhoorn; Joshua M Hare; Pascal J Goldschmidt-Clermont; Chunming Dong
Journal:  Circ Res       Date:  2012-10-16       Impact factor: 17.367

8.  HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells.

Authors:  Suchitra Natarajan; Sabine Hombach-Klonisch; Peter Dröge; Thomas Klonisch
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

Review 9.  HMGA2 and high-grade serous ovarian carcinoma.

Authors:  Jingjing Wu; Jian-Jun Wei
Journal:  J Mol Med (Berl)       Date:  2013-05-19       Impact factor: 4.599

10.  HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy.

Authors:  Heike Summer; Ou Li; Qiuye Bao; Lihong Zhan; Sabrina Peter; Padmapriya Sathiyanathan; Dana Henderson; Thomas Klonisch; Steven D Goodman; Peter Dröge
Journal:  Nucleic Acids Res       Date:  2009-05-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.